Correlation between intrahepatic hepatitis B virus cccDNA levels and other activity markers in patients with HBeAg-negative chronic hepatitis B infection

European Journal of Gastroenterology and Hepatology

Volumn 23, Issue 12, 2011, Pages 1185-1191

  Guner, Rahmet ^a   Karahocagil, Mustafa ^b   Buyukberber, Mehmet ^b   Kandemir, Ozlem ^c   Ural, Onur ^d   Usluer, Gaye ^e   Inan, Dilara ^f   Koksal, Iftihar ^g   Baykam, Nurcan ^h   Hizel, Kenan ^e   Yamazhan, Tansu ⁱ   Esen, Saban ^j   Tasyaran, Mehmet A ^a  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b YUZUNCU YIL UNIVERSITY   (Turkey)

^c MERSIN UNIVERSITY   (Turkey)

^d SELCUK UNIVERSITY   (Turkey)

^e GAZI UNIVERSITY   (Turkey)

^f AKDENIZ UNIVERSITY   (Turkey)

^g KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^h ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

ⁱ EGE UNIVERSITY   (Turkey)

^j ONDOKUZ MAYIS UNIVERSITY   (Turkey)

more..

Author keywords

hepatitis B core antigen; hepatitis B early antigen negative chronic hepatitis; hepatitis B surface antigen; hepatitis B virus; hepatitis B virus covalently closed circular DNA; immunohistochemistry; quantitative hepatitis B surface antigen

Indexed keywords

ALANINE AMINOTRANSFERASE; COVALENTLY CLOSED CIRCULAR DNA; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; UNCLASSIFIED DRUG; VIRUS DNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CORRELATION ANALYSIS; DISEASE ACTIVITY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SERODIAGNOSIS; VIRUS REPLICATION;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; DNA, CIRCULAR; DNA, VIRAL; FEMALE; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROGNOSIS; VIRUS REPLICATION; YOUNG ADULT;

EID: 80955123640     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32834ba13a     Document Type: Article

References (35)

1. Zoulim F. New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA. J Hepatol 2005; 42:302-308. (Pubitemid 40254242)
2. Yuen MF, Wong DK, Sum SS, Yuan H, Yuen JC, Chan AO, et al. Effect of lamivudine therapy on the serum covalently closed-circular (ccc) DNA of chronic hepatitis B infection. Am J Gastroenterol 2005; 100:1099-1103. (Pubitemid 40769047)
3. Wiegand J, Wedenmeyer H, Finger A, Heidrich B, Rosenau J, Michel G, et al. A decline in hepatitis B virus surface antigen (HBsAg) predicts clearance, but does not correlate with quantitative HBeAg or HBV DNA levels. Antivir Ther 2008; 13:547-554. (Pubitemid 352016717)
4. Manesis EK, Hadziyannis E, Angelopoulou OP, Hadziyannis SJ. Prediction of treatment-related HBsAg loss in HBeAg negative chronic hepatitis B: a clue from serum HBsAg levels. Antivir Ther 2007; 12:73-82. (Pubitemid 46340428)
5. Ozaras R, Tabak F, Tahan V, Ozturk R, Akin H, Mert A, et al. Correlation of quantitative assay of HBsAg and HBV DNA levels during chronic HBV treatment. Dig Dis Sci 2008; 53:2995-2998.
6. Volz T, Lutgehetmann M, Wachtler P, Jacob A, Quaas A, Murray JM, et al. Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patients. Gastroenterology 2007; 133:843-852. (Pubitemid 47374140)
7. Levrero M, Pollicino T, Petersen J, Belloni L, Raimondo G, Dandri M. Control of cccDNA function in hepatitis B virus infection. J Hepatol 2009; 51: 581-592.
8. Sohn JA, Litwin S, Seeger C. Mechanism for cccDNA synthesis in Hepadnaviruses. PLoS One 2009; 4:e8093.
9. Ozdemir FT, Duman D, Ertem D, Avsar E, Eren F, Ozdogan O, et al. Determination of hepatitis B genotypes in patients with chronic hepatitis B virus infection in Turkey. Turk J Gastroenterol 2005; 16:183-187. (Pubitemid 43266364)
10. Sunbul M, Leblebicioglu H. Distribution of hepatitis B virus genotypes in patients with chronic hepatitis B in Turkey. World J Gastroenterol 2005; 11:1976-1980. (Pubitemid 40520995)
11. Yuen MF, Ng IO, Fan ST, Yuan HJ, Wong DK, Yuen JC, et al. Significance of HBV DNA levels in liver histology of HBeAg and anti-HBe positive patients with chronic hepatitis B. Am J Gastroenterol 2004; 99:2032-2037. (Pubitemid 39421251)
12. Lindh M, Horal P, Dhillon AP, Norkrans G. Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B. J Viral Hepat 2000; 7:258-267.
13. Zavaglia C, Mondazzi L, Maggi G, Iamoni G, Gelosa F, Bellati G, et al. Are alanine aminotransferase, hepatitis B virus DNA or IgM antibody to hepatitis B core antigen serum levels predictors of histological grading in chronic hepatitis B? Liver 1997; 17:83-87. (Pubitemid 27179981)
14. Karayiannis P, Fowler MJ, Lok AS, Greenfield C, Monjardino J, Thomas HC. Detection of serum HBV-DNA by molecular hybridisation. Correlation with HBeAg/anti-HBe status, racial origin, liver histology and hepatocellular carcinoma. J Hepatol 1985; 1:99-106. (Pubitemid 15038040)
15. Bonino F, Rosina F, Rizzetto M, Rizzi R, Chiaberge E, Tardanico R, et al. Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe. Gastroenterology 1986; 90 (5 Pt 1):1268-1273. (Pubitemid 16145494)
16. Papatheodoridis GV, Manesis EK, Manolakopoulos S, Elefsiniotis S, Goulis J, Giannousis J, et al. Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection? Hepatology 2008; 48:1451-1459.
17. Chu CJ, Hussain M, Lok A. Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection. Hepatology 2002; 36:1408-1415. (Pubitemid 35407438)
18. Kumar M, Sarin SK, Hissar S, Pande C, Sakhuja P, Sharma BC, et al. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT. Gastroenterology 2008; 134:1376-1384. (Pubitemid 351615375)
19. Dusheiko G, Paterson A. Hepatitis B core and surface antigen expression in HBeAg and HBV DNA positive chronic hepatitis B: correlation with clinical and histological parameters. Liver 1987; 7:228-232. (Pubitemid 17156680)
20. Cahen DL, Van Leeuwen DJ, Ten Kate FJ, Blok AP, Oosting J, Chamuleau RA. Do serum ALAT values reflect the inflammatory activity in the liver of patients with chronic viral hepatitis? Liver 1996; 16:105-109. (Pubitemid 26128712)
21. Werle-Lapostelle B, Bowden S, Locarnini S, Wursthorn K, Petersen J, Lau G, et al. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 2004; 126:1750-1758. (Pubitemid 38736340)
22. Thompson AJ, Nguyen T, Iser D, Ayres A, Jackson K, Littlejohn M, et al. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers. Hepatology 2010; 51:1933-1944.
23. Wong DK, Yuen MF, Yuan H, Sum SS, Hui CK, Hall J, et al. Quantitation of covalently closed circular hepatitis B virus DNA in chronic hepatitis B patients. Hepatology 2004; 40:727-737. (Pubitemid 39265596)
24. Laras A, Koskinas J, Dimou E, Kostamena A, Hadziyannis SJ. Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients. Hepatology 2006; 44: 694-702. (Pubitemid 44433726)
25. Lutgehetmann M, Volzt T, Quaas A, Zankel M, Fischer C, Dandri M, et al. Sequential combination therapy leads to biochemical and histological improvement despite low ongoing intrahepatic hepatitis B virus replication. Antivir Ther 2008; 13:57-66. (Pubitemid 351541674)
26. Suzuki F, Miyakoshi H, Kobayashi M, Kumada H. Correlation between serum hepatitis B virus core-related antigen and intrahepatic covalently closed circular DNA in chronic hepatitis B patients. J Med Virol 2009; 81: 27-33.
27. Wursthorn K, Lutgehetmann M, Dandri M, Volz T, Buggisch P, Zollner B, et al. Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B. Hepatology 2006; 44:675-684. (Pubitemid 44433724)
28. Takkenberg RB, Terpstra V, Zaaijer HL, Weegink CJ, Dijkgraaf MG, Jansen PL, et al. Intrahepatic response markers in chronic hepatitis B patients treated with peginterferon alfa-2a and adefovir. J Gastroenterol Hepatol 2011 doi: 10.1111/j.1440-1746.2011.06766.x [Epub ahead of print].
29. Manesis EK, Papatheodoridis GV, Tiniakos D, Hadziyannis E, Agelopoulou O, Syminelaki T, et al. Hepatitis B surface antigen: relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B. J Hepatol 2011; 55:61-68.
30. Chan HL, Wong VW, Wong GL, Tse CH, Chan HY, Sung JJ. A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B. Hepatology 2010; 52:1232-1241.
31. Lin LY, Wong VW, Zhou HJ, Chan HY, Gui HL, Guo SM, et al. Relationship between serum hepatitis B virus DNA and surface antigen with covalently closed circular DNA in HBeAg-negative patients. J Med Virol 2010; 82:1494-1500.
32. Jaroszewicz J, Calle Serrano B, Wursthorn K, Deterding K, Schlue J, Raupach R, et al. Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective. J Hepatol 2010; 52:514-522.
33. Nguyen T, Thompson AJ, Bowden S, Croagh C, Bell S, Desmond PV, et al. Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia. J Hepatol 2010; 52:508-513.
34. Brunetto MR, Oliveri F, Colombatto P, Moriconi F, Ciccorossi P, Coco B, et al. Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers. Gastroenterology 2010; 139:483-490.
35. Huang YH, Hung HH, Chan CC, Lai CR, Chu CJ, Huo TI, et al. Core antigen expression is associated with hepatic necroinflammation in e antigen-negative chronic hepatitis B patients with low DNA loads. Clin Vaccine Immunol 2010; 17:1048-1053.